Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 906 (LINC00906) is a member of the long intergenic non-coding RNAs (lincRNAs) family, which are defined as autonomously transcribed non-coding RNAs longer than 200 nucleotides that do not overlap with annotated coding genes[1][3]. LincRNAs, including LINC00906, often act in the nucleus to regulate chromatin structure, transcription, and RNA stability, and may influence the expression of neighboring or distal genes through diverse mechanisms, sometimes functioning in a tissue-specific manner[1][3]. The biological functions of most individual lincRNAs—including LINC00906—remain under-explored, and there is currently no published evidence to support LINC00906 as a direct therapeutic target or a disease biomarker. However, the class to which it belongs (lincRNAs) can play roles in fine-tuning gene expression and may be involved in disease processes, but LINC00906 itself is not classified as a receptor, enzyme, transporter, or traditional therapeutic target[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 906 (LINC00906).